Form 4: Tyra Biosciences CFO Alan Fuhrman Acquires 9,500 Shares of Common Stock

Alan Fuhrman, CFO of Tyra Biosciences, recently purchased 9,500 shares of the company's common stock at an average price of $15.9952 per share.

Summary

• On October 30, 2024, Alan Fuhrman, the Chief Financial Officer of Tyra Biosciences, acquired 9,500 shares of common stock.
• The purchase was made at a weighted average price of $15.9952 per share, with individual prices ranging from $15.95 to $16.00.
• Following the transaction, Fuhrman directly owns 12,849 shares of Tyra Biosciences common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed favorably, but the purchase is relatively small and may not be highly significant.

Positives

• The CFO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that a company insider believes the company's stock is undervalued. However, it's just one factor to consider when evaluating a stock.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates